organ-specific characteristics of the cochlear blood-tissue barrier. In particular, the primary cell lines enable direct study of intercellular interactions between ECs, PCs and PVM/Ms in coculture models, which is relevant for a better understanding of transport processes, including drug delivery. The models provide new insight into the mechanisms of the cochlear blood-tissue barrier, particularly for the specific contribution of component cells to bloodlabyrinth barrier integrity. These newly developed primary cell lines have enabled the identification of the role of PVM/Ms in controlling the integrity of the intrastrial fluid-blood barrier 5 .
Cell lines gradually lose their phenotype with passaging. The method provides a ready source of barrier cell types. Moreover, as confluent monolayers of cell lines can be shipped to other laboratories, experiments with the in vitro model using standardized protocols on the same cell stock can be repeated for robust testing of hypotheses.
Comparison with other methods, including our previously published method To our knowledge, this is the first protocol that describes a method for culturing the three primary cell types of the bloodlabyrinth barrier from the mouse ear (ECs, PCs and PVM/Ms). This method is qualitatively different from the methods previously published for obtaining comparable cell lines. Typically, the cell lines are cultured from brain, umbilical vein, lung or kidney tissues in mouse, rat, bovine and human models, and initial cell number has not been a limiting factor for these methods. The blood-labyrinth barrier in the stria vascularis consists of less than 5,000 cells in one ear, and methods that rely on abundant initial stock are not practical. The current protocol is a modified version of the protocol we published earlier 5 , but is as used in ref. 22 .
In our initial protocol, we used mice that were a couple of days younger (P7-P10). We encountered difficulties in working with mice at this age, as, within the range of genetic differences, the stria vascularis was not consistently fully formed and separated from the spiral ligament (according to Iwagaki et al. 23 , external wall vessels are a single-layer capillary network at birth, and this single layer subsequently divides into two layers, constituting the microvessels of the stria vascularis and spiral ligament between days 5 and 8 in mice). In addition, tissue and bone at this age are very soft and fragile, and it is difficult to obtain good separation. Frequently, tissues were mechanically crushed, with major cell damage. In the current version of the protocol, mice aged P10-P15 are used, which presents less of a surgical challenge, and the rigidity of the stria vascularis lends itself to easy detachment from the spiral ligament. Most notably, the cells are still highly proliferative.
Previously, pieces of the stria vascularis were cut to ~1 mm 3 in size. Although the first passage of the primary cell line could be generated in a 10-d frame, cell yield was much lower. The slower growth is attributed to the restricted access that larger-sized explants have to the nutrients in the growth medium. The bloodlabyrinth barrier in the stria vascularis 24 junctions. Blood-barrier component cells may be sensitive to nutrient level and show less growth under starvation conditions. In the current protocol, the stria vascularis is torn into pieces the size of little seeds (0.15-0.20 mm 3 ) and uniformly bathed in their growth medium. This procedure reliably produces a large population of ECs, PCs and PVM/Ms. We established the previous protocol to answer a more restricted question-whether PVM/Ms affect blood-labyrinth barrier integrity-and for this purpose, we needed only ECs and PVM/Ms from the stria vascularis explants. With the current chip method, a cell line of the third major barrier cell type (PCs) is produced.
A major concern in PC cell lines is EC contamination 18, 25, 26 . In our protocol, the culture medium for PC growth contains pigment epithelium-derived growth factor (PEDF) at a concentration of 100 nM. This growth factor promotes PC proliferation and reduces EC contamination by suppressing EC growth 27, 28 .
Overall, this method of producing high-quality ECs, PCs and PVM/Ms is simple and reliable. This method is especially suitable for obtaining these cell types from organs and tissues of small volume and high anatomical complexity, such as the capillaries of the inner ear. Although cells can be obtained by experimenters with very little training, results improve over a 2-3-month time frame.
• REAGENT SETUP Anesthetic For 1 ml of anesthetic solution, combine 0.2 ml of 100 mg ml − 1 ketamine hydrochloride, 0.2 ml of 20 mg ml − 1 xylazine and 0.6 ml of bacteriostatic 0.9% (wt/vol) NaCl. The solution should be freshly prepared before use. Isolation medium (artificial perilymph solution) To prepare isolation medium, add 125 mM NaCl, 3.5 mM KCl, 1.3 mM CaCl2, 1.5 mM MgCl2, 0.51 mM NaH2PO4, 10 mM HEPES and 5 mM glucose at pH 7.4, with osmolarity adjusted to 310 mmol kg − 1 . Filter the solution (0.22-µm filter) and keep it on ice throughout the experiment. The prepared solution can be used for up to 1 week when stored at 4 °C. EC culture medium For 100 ml of medium, combine 10 ml of FBS, 1 ml of penicillin-streptomycin solution, 1 ml of ECGF and 88 ml of CS-C medium without serum. Strain the medium through a 0.22-µm filter. PC culture medium For 100 ml of medium, combine 10 ml of FBS, 1 ml of penicillin-streptomycin solution and 89 ml of DMEM low glucose. Add PEDF to the solution to a final concentration of 100 nM. PVM/Ms culture medium For 100 ml of medium, combine 10 ml of FBS, 200 µl of gentamicin/amphotericin B solution, 1 ml of HMGS and 88.8 ml of medium 254CF. Add CaCl 2 (provided with medium 254CF) to the solution to a final concentration of 0.2 mM.  crItIcal All culture media should be labeled with the storage conditions and expiration date. We recommend using prepared solutions for only up to 1 week when stored at 4 °C. PBS-BSA solution, 1% (wt/vol) Dissolve 1 g of BSA in 100 ml of PBS  crItIcal The solution can be stored at 4 °C for several weeks.
Immunofluorescence blocking solution For 10 ml of a 10% (vol/vol) goat serum PBS-BSA solution, combine 1 ml of goat serum and 9 ml of 1% (wt/vol) PBS-BSA solution. For 10 ml of a 10% (vol/vol) donkey serum PBS-BSA solution, combine 1 ml of donkey serum and 9 ml of 1% (wt/vol) PBS-BSA solution.  crItIcal The solution can be stored at −20 °C for several weeks. Agarose gel, 1.5% (wt/vol) Add 0.45 g of agarose powder and 3 µl of SYBR Safe DNA gel stain to 30 ml of 1 × TBE buffer. Carefully heat the mixture until the agarose is completely dissolved. Allow the resulting solution to cool at room temperature (25 °C) for 20 min. Pour the solution immediately into a casting tray. Allow the gel to form at room temperature over a period of at least 30 min. The gels are stable for several weeks at 4 °C when protected from light.
Cryopreservation medium Supplement the cell complete medium with 10% (vol/vol) DMSO and increase the serum in the medium to 20% (vol/vol). For 10 ml of the cryopreservation medium, combine 8 ml of cell complete medium, 1 ml of DMSO and 1 ml of FBS.  crItIcal The medium should be freshly prepared before use. EQUIPMENT SETUP Biosafety cabinet (hood) Turn on the UV light 30 min before performing the experiments. Scissors and tweezers Autoclave the scissors and tweezers before the experiment.
• Power supply for agarose gel electrophoresis Set up the power supply to 100 V and to a running time of 30 min.
CytoVu/SiMPore thin membrane coculture system Autoclave the slide before use and incubate it with cell culture medium overnight in the incubator before seeding the cells. Sapphire disk preparation Clean disks with detergent or 70% (vol/vol) ethanol and rinse them thoroughly with ddH 2 O. Deposit a medium, dark film of carbon on the surface of the grid using a carbon coater. Scratch an asymmetric character (e.g., 'F') into the carbon layer to denote the sample side. Bake the disks overnight at 120 °C to secure the carbon film to the sapphire disks and prevent it from coming off in the culture dish. Secure disks (uncoated side down) to a culture dish with a small amount of agarose. Sterilize the entire assembly via UV or microwave before adding cells and medium.
proceDure collection of the cochlear stria vascularis from young mouse ear • tIMInG ~1 h 1| Prepare anesthetic, fresh artificial perilymph solution, culture medium and collagen I-coated dishes before starting the experiment (Reagent Setup and Equipment Setup).
2|
Weigh three P10-P15 C57BL/6J mice and anesthetize them with a dose of 0.1 ml per 20 g of body weight of anesthetic cocktail. Anesthetize the chest area topically with 1% lidocaine HCl at a concentration of 10 mg ml − 1 , and euthanize the mice by intracardial injection with 0.2 ml of the euthanasia solution. Monitor the respiration and heart rate of the mice until both respiration and heart function cease. ! cautIon The procedures involving mouse surgery and the use of mouse tissue must be reviewed and approved by your Institutional Animal Care and Use Committee. In the US, a DEA license is required.  crItIcal step Mice <P7 are too young, and at this age the stria vascularis has not yet separated from the spiral ligament. Choose P10-P15 animals for your experiments.
3|
Swab the head and neck of the mouse with ethanol.
4|
Decapitate mice with sharp scissors, and rapidly remove and place the auditory bullae in a Petri dish filled with cold, fresh artificial perilymph solution (the isolation medium is kept in the refrigerator at 4 °C).  crItIcal step Perform the surgery under sterile conditions.
5|
Gently pull away the stria vascularis from the cochlear spiral ligament and place it in ice-cold perilymph solution. The isolation of the stria vascularis should be completed in less than 1 h.  crItIcal step The isolation solution should not be more than 1 week old. The isolation procedure should be performed as fast as possible to minimize cell damage.
? trouBlesHootInG preparing mini-chip explants of cochlear stria vascularis from whole-mounted tissue • tIMInG ~1 h 6| Wash the isolated stria vascularis by gentle shaking in cool perilymph solution for 10 min.
7|
Transfer the stria vascularis into a clean 35-mm collagen I-coated dish with 2 ml of cell culture medium. (EC growth medium should be used for growing ECs. Similarly, PC and PVM/M growth medium should be used for growing PCs and PVM/Ms.)
8|
Tear the stria vascularis into small 0.15-0.20-mm 3 pieces with new and sterile ophthalmic tweezers under a dissection microscope.  crItIcal step Use new and sharp ophthalmic tweezers (size no. 5). Gently, evenly and in an orderly manner cut the stria vascularis from the apex to the basal end. In general, this procedure is completed in ~60 min.
? trouBlesHootInG 9| Allow the fragmented pieces of stria vascularis to settle by gravity and reposition them to uniform density.  crItIcal step The tissue tends to stick to the tips of the forceps. Tissues should be grasped in the forceps about two-thirds of the way up from the tip.  crItIcal step Results will improve with the experimenter′s experience. Improvement will be seen in the first 2 or 3 months of using this protocol. 12| Check on cell clone formation on the second day after seeding under a sterile phase-contrast microscope and change the first cell growth medium on the third day.  crItIcal step Do not change the medium in the first 2 d, and do not move the dish in the first 24 h.
13|
When the cells reach 90% confluency, remove the medium and wash the cultures with PBS (three times for 5 min); follow this by incubation in trypsin-EDTA solution for 5 min at 37 °C and 5% CO 2 . Pipette the cell suspension up and down a few times to detach the cell colony. cell purity assessment with Facs • tIMInG ~3 h 19| Detach the cells as described in Step 14 using a trypsin-EDTA solution.
20|
Gently wash the cells with 2 ml of culture medium and centrifuge at 300g for 5 min at 4 °C. Carefully aspirate the supernatant.
21|
Resuspend the cell pellet to 1 × 10 7 cells ml − 1 in its own culture medium. npg galactose is used as control. For PCs, use phycoerythrin-conjugated rat mAb for PDGFR-β at a concentration of 0.5 µg ml − 1 .
Rat IgG phycoerythrin at a concentration of 0.2 µg ml − 1 serves as the isotype control. For PVM/Ms, use phycoerythrinconjugated rat mAb for F4/80 at a concentration of 10 µl per 10 6 cells (in 100 µl). Rat IgG phycoerythrin at a concentration of 0.2 µg ml − 1 serves as the isotype control.  crItIcal step Antibodies should be incubated in the dark at 4 °C.
23| Add 2 ml of culture medium to the cells and vortex and centrifuge the cells at 300g for 5 min at 4 °C. Discard the supernatant and wash the cells again in 1 ml of culture medium.
24|
Resuspend the cell pellet in 500 µl of culture medium in a 5-ml polypropylene round-bottom tube for sorting.  crItIcal step Keep the cells on ice before sorting.
25|
Analyze and sort the cells with a BD influx cell sorter at 45 p.s.i. using a 70-µm nozzle. 
28|
Once the cells are detached, add 2 ml of medium to the dish and transfer the cells to a 5-ml polypropylene roundbottom tube.
29| Count the cells using trypan blue stain for a viable cell count.  crItIcal step The viability should be over 90% to ensure that the cells are healthy enough for freezing.
30| Spin down at 300g for 5 min at 4 °C and remove the medium.
31|
Resuspend the cells in enough cryopreservation medium to create a cell suspension of 1 × 10 6 cells per ml. Pipette the cells up and down to ensure a uniform mixture; aliquot 1 ml of the cell suspension into a cryogenic vial (in general, 1 × 10 6 cells per cryogenic vial is desired).
32|
Store the cryogenic vial in a Nalgene Cryo 1 °C freezing container overnight in a −86 °C freezer.
33|
Store the cryogenic vial in liquid nitrogen for long-term storage after Step 32.  crItIcal step Investigators should wear gloves, maintain hygienic conditions, use fresh plasticware when possible, autoclave the instruments and use sterile solutions. 
npg
? trouBlesHootInG Troubleshooting advice can be found in table 1.
• tIMInG Steps 1-5, collection of cochlear stria vascularis from young mouse ear: ~1 h Steps 6-9, preparation of mini-chip explants of stria vascularis from whole-mounted tissue: ~1 h Steps 10-17, selective culture of phenotypes: 17-24 d
Step 18A, immunofluorescence: 24 h (plus 2 h 30 min, plus overnight, plus 2 h on the following day)
Step 18B, validation of morphology: 24 h (plus 2 h 30 min, plus overnight, plus 2 h on the following day)
Step 18C, SEM: ~32 h
Step Figure 4a , are large, flat and stellate shaped with a broad filopod morphology, similar to that described by Shepro and Morel [29] [30] [31] . The PVM/Ms (Fig. 4b) previously identified as melanocytes 5 , have unique dendritic processes 32 . ECs (Fig. 4c) have flat, elongated and generally cuboidal morphology, which is consistent with an early report 33 . More details on the morphology of the three cell lines are shown in SEM (Fig. 4d-f) .
Cell purity and cell line phenotype should be assessed and validated by FACS. The method provides high-quality ECs, PCs and PVM/Ms with a purity >90% after two passages (Fig. 5) . (Fig. 5j-l) . The mean purity from multiple FACS analyses is 94 ± 2% (ECs, mean ± s.e.m., n = 6), 93 ± 3% (PCs, mean ± s.e.m., n = 5) and 93 ± 6% (PVM/Ms, mean ± s.e.m., n = 3). Percentage loss in each cell line from FACS analysis is ~25% (Fig. 5m-o) . 
